
© 2025 börsennews.de
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 31,350 | 31,670 | 19:13 | |
| 31,520 | 31,590 | 19:12 |

| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16:38 | Eilmeldung am Abend: NOVO NORDISK A/S wackelt gefährlich! | ||
| 15:30 | WARNUNG für Novo nordisk-Anleger: Steht die Aktie vor einem Kursdesaster? - Was das für Ihr Depot bedeutet | ||
| 15:12 | Novo touts Wegovy pill after U.S. approval of Lilly's Foundayo | ||
| 14:35 | Wall Street sees multi-billion dollar debut for Lilly's obesity pill despite Novo lead | ||
| 14:06 | NOVO NORDISK INC.: Wegovy pill demonstrated greater weight loss than orforglipron and lower odds of stopping medication due to side effects in a new indirect comparison to be presented at Obesity Medicine Association 2026 | Oral semaglutide 25 mg demonstrated significantly greater mean weight loss than orforglipron 36 mg in a population-adjusted indirect treatment comparison (ITC) using data from the OASIS 4... ► Artikel lesen |